KETAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ketamine Hydrochloride, and what generic alternatives are available?
Ketamine Hydrochloride is a drug marketed by Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, and Hospira. and is included in five NDAs.
The generic ingredient in KETAMINE HYDROCHLORIDE is ketamine hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ketamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ketamine Hydrochloride
A generic version of KETAMINE HYDROCHLORIDE was approved as ketamine hydrochloride by HIKMA on March 22nd, 1996.
Summary for KETAMINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Clinical Trials: | 1,208 |
Patent Applications: | 2,773 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KETAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for KETAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rush University Medical Center | Phase 1/Phase 2 |
Congressionally Directed Medical Research Programs | Phase 1/Phase 2 |
Grace Lim, MD, MS | Phase 1 |
Pharmacology for KETAMINE HYDROCHLORIDE
Drug Class | General Anesthetic |
Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for KETAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for KETAMINE HYDROCHLORIDE
US Patents and Regulatory Information for KETAMINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eugia Pharma | KETAMINE HYDROCHLORIDE | ketamine hydrochloride | INJECTABLE;INJECTION | 076092-001 | Sep 30, 2008 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Gland Pharma Ltd | KETAMINE HYDROCHLORIDE | ketamine hydrochloride | INJECTABLE;INJECTION | 216809-002 | Jan 24, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Fresenius Kabi Usa | KETAMINE HYDROCHLORIDE | ketamine hydrochloride | INJECTABLE;INJECTION | 215808-001 | Jan 13, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | KETAMINE HYDROCHLORIDE | ketamine hydrochloride | INJECTABLE;INJECTION | 074549-002 | Jun 27, 1996 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |